U.S. flag

An official website of the United States government

NM_000038.6(APC):c.1370C>G (p.Ser457Ter) AND Hereditary cancer-predisposing syndrome

Germline classification:
Pathogenic (1 submission)
Last evaluated:
Jun 13, 2023
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000491762.13

Allele description [Variation Report for NM_000038.6(APC):c.1370C>G (p.Ser457Ter)]

NM_000038.6(APC):c.1370C>G (p.Ser457Ter)

Gene:
APC:APC regulator of WNT signaling pathway [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
5q22.2
Genomic location:
Preferred name:
NM_000038.6(APC):c.1370C>G (p.Ser457Ter)
HGVS:
  • NC_000005.10:g.112821953C>G
  • NG_008481.4:g.134433C>G
  • NM_000038.6:c.1370C>GMANE SELECT
  • NM_001127510.3:c.1370C>G
  • NM_001127511.3:c.1316C>G
  • NM_001354895.2:c.1370C>G
  • NM_001354896.2:c.1370C>G
  • NM_001354897.2:c.1400C>G
  • NM_001354898.2:c.1295C>G
  • NM_001354899.2:c.1286C>G
  • NM_001354900.2:c.1193C>G
  • NM_001354901.2:c.1193C>G
  • NM_001354902.2:c.1097C>G
  • NM_001354903.2:c.1067C>G
  • NM_001354904.2:c.992C>G
  • NM_001354905.2:c.890C>G
  • NM_001354906.2:c.521C>G
  • NP_000029.2:p.Ser457Ter
  • NP_001120982.1:p.Ser457Ter
  • NP_001120983.2:p.Ser439Ter
  • NP_001341824.1:p.Ser457Ter
  • NP_001341825.1:p.Ser457Ter
  • NP_001341826.1:p.Ser467Ter
  • NP_001341827.1:p.Ser432Ter
  • NP_001341828.1:p.Ser429Ter
  • NP_001341829.1:p.Ser398Ter
  • NP_001341830.1:p.Ser398Ter
  • NP_001341831.1:p.Ser366Ter
  • NP_001341832.1:p.Ser356Ter
  • NP_001341833.1:p.Ser331Ter
  • NP_001341834.1:p.Ser297Ter
  • NP_001341835.1:p.Ser174Ter
  • LRG_130:g.134433C>G
  • NC_000005.9:g.112157650C>G
  • NM_000038.5:c.1370C>G
  • NM_001127510.2:c.1370C>G
  • p.Ser457*
Protein change:
S174*
Links:
dbSNP: rs1060503333
NCBI 1000 Genomes Browser:
rs1060503333
Molecular consequence:
  • NM_000038.6:c.1370C>G - nonsense - [Sequence Ontology: SO:0001587]
  • NM_001127510.3:c.1370C>G - nonsense - [Sequence Ontology: SO:0001587]
  • NM_001127511.3:c.1316C>G - nonsense - [Sequence Ontology: SO:0001587]
  • NM_001354895.2:c.1370C>G - nonsense - [Sequence Ontology: SO:0001587]
  • NM_001354896.2:c.1370C>G - nonsense - [Sequence Ontology: SO:0001587]
  • NM_001354897.2:c.1400C>G - nonsense - [Sequence Ontology: SO:0001587]
  • NM_001354898.2:c.1295C>G - nonsense - [Sequence Ontology: SO:0001587]
  • NM_001354899.2:c.1286C>G - nonsense - [Sequence Ontology: SO:0001587]
  • NM_001354900.2:c.1193C>G - nonsense - [Sequence Ontology: SO:0001587]
  • NM_001354901.2:c.1193C>G - nonsense - [Sequence Ontology: SO:0001587]
  • NM_001354902.2:c.1097C>G - nonsense - [Sequence Ontology: SO:0001587]
  • NM_001354903.2:c.1067C>G - nonsense - [Sequence Ontology: SO:0001587]
  • NM_001354904.2:c.992C>G - nonsense - [Sequence Ontology: SO:0001587]
  • NM_001354905.2:c.890C>G - nonsense - [Sequence Ontology: SO:0001587]
  • NM_001354906.2:c.521C>G - nonsense - [Sequence Ontology: SO:0001587]

Condition(s)

Name:
Hereditary cancer-predisposing syndrome
Synonyms:
Neoplastic Syndromes, Hereditary; Tumor predisposition; Cancer predisposition; See all synonyms [MedGen]
Identifiers:
MONDO: MONDO:0015356; MeSH: D009386; MedGen: C0027672

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000579843Ambry Genetics
criteria provided, single submitter

(Ambry Variant Classification Scheme 2023)
Pathogenic
(Jun 13, 2023)
germlineclinical testing

PubMed (4)
[See all records that cite these PMIDs]

Citation Link

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Novel APC mutations in Czech and Slovak FAP families: clinical and genetic aspects.

Stekrova J, Sulova M, Kebrdlova V, Zidkova K, Kotlas J, Ilencikova D, Vesela K, Kohoutova M.

BMC Med Genet. 2007 Apr 5;8:16.

PubMed [citation]
PMID:
17411426
PMCID:
PMC1853078

Familial adenomatous polyposis: experience from a study of 1164 unrelated german polyposis patients.

Friedl W, Aretz S.

Hered Cancer Clin Pract. 2005 Sep 15;3(3):95-114. doi: 10.1186/1897-4287-3-3-95.

PubMed [citation]
PMID:
20223039
PMCID:
PMC2837297
See all PubMed Citations (4)

Details of each submission

From Ambry Genetics, SCV000579843.7

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (4)

Description

The p.S457* pathogenic mutation (also known as c.1370C>G), located in coding exon 10 of the APC gene, results from a C to G substitution at nucleotide position 1370. This changes the amino acid from a serine to a stop codon within coding exon 10. This mutation has been identified in multiple individuals/families with familial adenomatous polyposis or attenuated familial adenomatous polyposis (Friedl W et al. Hered Cancer Clin Pract. 2005 Sep;3:95-114; Stekrova J et al. BMC Med. Genet. 2007;8:16; Lagarde A et al. J. Med. Genet. 2010 Oct;47:721-2). This variant is considered to be rare based on population cohorts in the Genome Aggregation Database (gnomAD). This alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. As such, this alteration is interpreted as a disease-causing mutation.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Nov 10, 2024